Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac HPBCD for acute dental pain
NCT00942448Phase 3Completed
- Sponsor
- IBSA Group
- Start
- Sep 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of diclofenac HPBCD in postoperative pain (4 arms), sponsored by IBSA Group. Primary endpoint: Pain Intensity Difference at 1.5 hours. Started Sep 2009; status: completed.
02
Drugs
diclofenac HPBCD
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00942448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942448.